Nuvation Bio Inc. (NUVB) Operating income 2020–2025
Nuvation Bio Inc. (NUVB) annual operating income history from SEC filings — each fiscal year as reported.
-$213.1MFY2025 · since FY2020: -$43.6M → -$213.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$213.1M | +64.0% |
| FY2024 | -$592.6M | -493.7% |
| FY2023 | -$99.8M | +16.6% |
| FY2022 | -$119.7M | -28.3% |
| FY2021 | -$93.3M | -114.3% |
| FY2020 | -$43.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NUVB financial trends
NUVB RevenueNUVB Net incomeNUVB Net marginNUVB Gross profitNUVB Gross marginNUVB Operating marginNUVB Operating cash flowNUVB Free cash flowNUVB Capital expendituresNUVB Return on equityNUVB Stock buybacksNUVB Dividends paidNUVB Total assetsNUVB Total liabilitiesNUVB Shareholders’ equityNUVB overview →